XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

Name: XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
Published: 2021
License: Public Domain

Xenon Pharmaceuticals Inc. · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

disease epilepsy seizure

epilepsy, epilepsy in children, epilepsy; seizure, disease, brain diseases, central nervous system diseases, nervous system diseases, epileptic syndromes, xen496, ezogabine, retigabine, encephalopathy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 892883
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.